AbbVie has ended speculation about what it will charge for its newly-approved Vuity therapy for presbyopia, a sight condition characterised by difficulty in focusing on near objects. The company told ...

The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects. The ...

As we age, our vision undergoes natural changes, including difficulty focusing on near objects (presbyopia) and reduced light sensitivity. Common age-related eye conditions like cataracts, glaucoma, ...

ATHERTON, Calif.--(BUSINESS WIRE)--TearOptix, Inc., a pioneering contact lens company developing advanced solutions for patients with presbyopia, today announced the completion of a strategic ...

Presbyopia is a decline in your vision when your eyes lose the ability to focus on things close to you. In spite of the big name, it isn't a disease. It's a natural part of the aging process, and it's ...

Please provide your email address to receive an email when new articles are posted on . Staff can be trained to collect information about patients’ lifestyles from ...

The FDA approved pilocarpine hydrochloride ophthalmic solution (Qlosi) for adults with presbyopia, according to a statement from Orasis Pharmaceuticals. The approval allows for daily or as-needed use, ...

As people age, many develop presbyopia — age-related farsightedness that makes it hard to read things at close range — and may turn to reading glasses. But new research suggests another option may be ...

Share on Pinterest Scientists have developed new eye drops that could help with presbyopia. Ekaterina Vasileva-Bagler/Getty Images Researchers estimate that about 1.8 billion people around the world ...

A new prescription eye drop that could potentially allow many people to put down their reading glasses has been approved by the U.S. Food and Drug Administration (FDA). Known as Vizz, manufactured by ...

Presbyopia is, unfortunately, an inevitable condition associated with aging. Almost everyone over the age of 45 experiences this near-sight vision loss, which gradually gets worse and usually requires ...

Lenz Therapeutics has earned the FDA’s go-ahead for its aceclidine eye drop to crack the large presbyopia market, where past efforts by other drug developers have mostly been unsuccessful. The ...